These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4722209)

  • 21. Relationship of biogenic amines to behavior.
    Breese GR; Cooper BR; Hollister AS
    J Psychiatr Res; 1974; 11():125-33. PubMed ID: 4282384
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacologic properties and mechanism of action of amfonelic acid.
    Aceto MD; Botton I; Martin R; Levitt M; Bentley HC; Speight PT
    Eur J Pharmacol; 1970; 10(3):344-54. PubMed ID: 4393073
    [No Abstract]   [Full Text] [Related]  

  • 23. The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
    Kostowski W; Czlonkowski A
    Pharmacology; 1973; 10(2):82-7. PubMed ID: 4797045
    [No Abstract]   [Full Text] [Related]  

  • 24. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-hydroxyindole levels in rat brain after inhibition of dopamine -hydroxylase.
    Johnson GA; Kim EG; Boukma SJ
    J Pharmacol Exp Ther; 1972 Mar; 180(3):539-46. PubMed ID: 5012781
    [No Abstract]   [Full Text] [Related]  

  • 26. Some observations on the site of action of oxypertin.
    Fuxe K; Grobecker H; Hökfelt T; Jonsson J; Malmfors T
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(4):450-63. PubMed ID: 5622482
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhanced behavioral depressant effects of reserpine and -methyltyrosine after 6-hydroxydopamine treatment.
    Cooper BR; Breese GR; Howard JL; Grant LD
    Psychopharmacologia; 1972; 27(2):99-110. PubMed ID: 4638213
    [No Abstract]   [Full Text] [Related]  

  • 28. Social environment and brain biogenic amine metabolism in rats.
    Stolk JM; Conner RL; Barchas JD
    J Comp Physiol Psychol; 1974 Aug; 87(2):203-7. PubMed ID: 4279254
    [No Abstract]   [Full Text] [Related]  

  • 29. Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs.
    Keller HH; Bartholini G; Pletscher A
    Eur J Pharmacol; 1973 Aug; 23(2):183-6. PubMed ID: 4733777
    [No Abstract]   [Full Text] [Related]  

  • 30. Decrease in rat striatal acetylcholine levels by some direct- and indirect-acting dopaminergic antagonists.
    Consolo S; Ladinsky H; Bianchi S
    Eur J Pharmacol; 1975; 33(2):345-51. PubMed ID: 1183479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of catecholaminergic drugs upon memory storage processes in mice.
    Haycock JW; Van Buskirk R; McGaugh JL
    Behav Biol; 1977 Jul; 20(3):281-310. PubMed ID: 19010
    [No Abstract]   [Full Text] [Related]  

  • 32. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.
    Andén NE; Strömbom U
    Psychopharmacologia; 1974; 38(2):91-103. PubMed ID: 4533319
    [No Abstract]   [Full Text] [Related]  

  • 33. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse.
    Thornburg JE; Moore KE
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):158-67. PubMed ID: 4399378
    [No Abstract]   [Full Text] [Related]  

  • 34. Behavioral effects of alpha-methyltyrosine after prior depletion of brain catecholamines.
    Rech RH; Carr LA; Moore KE
    J Pharmacol Exp Ther; 1968 Apr; 160(2):326-35. PubMed ID: 5651375
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of dopamine and norepinephrine in the chemistry of reward.
    Fibiger HC; Phillips AG
    J Psychiatr Res; 1974; 11():135-43. PubMed ID: 4461785
    [No Abstract]   [Full Text] [Related]  

  • 36. Operant behavior and catecholamine-containing neurons: prolonged increase in lever-pressing after 6-hydroxydopamine.
    Schoenfeld RI; Uretsky NJ
    Eur J Pharmacol; 1972 Dec; 20(3):357-62. PubMed ID: 4643457
    [No Abstract]   [Full Text] [Related]  

  • 37. The action of neuroleptics in rats with altered catecholamine metabolism. IV. Behavioral and biochemical effects of chlorpromazine and haloperidol in rats pretreated with inhibitors of dopamine-beta-hydroxylase.
    Vetulani J
    Arch Immunol Ther Exp (Warsz); 1973; 21(3):501-6. PubMed ID: 4730817
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cellular effect of neuroleptics].
    Kuschinsky K
    Dtsch Med Wochenschr; 1975 Jun; 100(25):1405-8. PubMed ID: 237751
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydoxydopamine.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):895-9. PubMed ID: 1208632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.